Clincosm LogoSign in Get a demo

Prostate Adenocarcinoma

Showing NaN - NaN of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma Trial in Rochester (Ulrasound Vibroelastography (UVE))

Suspended
  • Prostate Adenocarcinoma
  • Ulrasound Vibroelastography (UVE)
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester

Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Androgen Suppression
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Jan 5, 2023

Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester

Active, not recruiting
  • Metastatic Prostate Adenocarcinoma
  • +6 more
  • Intensity-Modulated Radiation Therapy
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Metastatic Prostate Cancer, Prostate Adenocarcinoma Trial in Worldwide (Cabozantinib, Atezolizumab, Abiraterone Acetate)

Recruiting
  • Metastatic Prostate Cancer
  • Prostate Adenocarcinoma
  • Tucson, Arizona
  • +259 more
Oct 19, 2022

Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in United States

Recruiting
  • Prostate Adenocarcinoma
  • +6 more
  • Gonadotrophin Releasing Hormone
  • +2 more
  • Gilbert, Arizona
  • +86 more
Sep 27, 2022

Prostate Adenocarcinoma, Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial in Canada, Switzerland, United

Active, not recruiting
Has Results
  • Prostate Adenocarcinoma
  • +3 more
  • Hypofractionated radiation therapy
  • +2 more
  • Birmingham, Alabama
  • +240 more
Jun 6, 2022

Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

Active, not recruiting
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • Quality-of-Life Assessment
  • Scottsdale, Arizona
  • +2 more
Feb 3, 2022

Prostate Adenocarcinoma, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Rochester (Goserelin Acetate, Laboratory

Terminated
Has Results
  • Prostate Adenocarcinoma
  • +4 more
  • Goserelin Acetate
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Dec 9, 2019

Solid Tumors, Urothelial Carcinoma, Gastric Carcinoma Trial in United States (MM-310)

Unknown status
  • Solid Tumors
  • +11 more
  • Scottsdale, Arizona
  • +4 more
Feb 26, 2018

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Canada, United States (drug,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Fairbanks, Alaska
  • +169 more
Feb 23, 2018

Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (drug, other, procedure)

Completed
Has Results
  • Prostate Adenocarcinoma
  • +4 more
  • Los Angeles, California
  • +14 more
Sep 18, 2017

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (drug, other,

Terminated
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Jacksonville, Florida
  • +13 more
Aug 21, 2017

Prostate Adenocarcinoma, Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Rochester (Bicalutamide, Flutamide, Goserelin

Completed
Has Results
  • Prostate Adenocarcinoma
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Apr 6, 2017

Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (Cholecalciferol, Genistein,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +3 more
  • Birmingham, Alabama
  • +10 more
Jun 20, 2016